e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma and corticosteroids: time for a more precise approach to treatment
Eleanor M. Dunican, John V. Fahy
Source:
Eur Respir J, 49 (6) 1701167; 10.1183/13993003.01167-2017
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Eleanor M. Dunican, John V. Fahy. Asthma and corticosteroids: time for a more precise approach to treatment. Eur Respir J, 49 (6) 1701167; 10.1183/13993003.01167-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Asthma paradoxes: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 53 (4) 1900218; 10.1183/13993003.00218-2019
Year: 2019
Asthma paradoxes: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 53 (4) 1802329; 10.1183/13993003.02329-2018
Year: 2019
Comparative effectiveness of paediatric asthma step-up options: Increasing ICS dose vs adding separate LABA
Source: International Congress 2014 – Paediatric asthma: what is new for the clinician?
Year: 2014
Once-daily inhaled corticosteroids in children with asthma: Not a simple solution for non-adherence
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Asthma control and medication use five years after early or delayed introduction of inhaled corticosteroids in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Do correct steps using pMDI technique with spacer predict no exacerbations of Asthma or COPD?
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma?
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013
Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
A predictive model of failed stepping-down of inhaled corticosteroids in adult asthmatics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Effect of 1 year treatment with inhaled corticosteroids with electronically assessed adherence on height growth in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
The role of adherence to inhaled corticosteroids (ICS) in the relationship between blood eosinophilia and asthma control
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Asthma rescue treatments, time to reboot
Source: Eur Respir J, 55 (4) 2000542; 10.1183/13993003.00542-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept